1
|
He W, Cui B, Chu Z, Chen X, Liu J, Pang X, Huang X, Yin H, Lin H, Peng L. Radiomics based on HRCT can predict RP-ILD and mortality in anti-MDA5 + dermatomyositis patients: a multi-center retrospective study. Respir Res 2024; 25:252. [PMID: 38902680 PMCID: PMC11191144 DOI: 10.1186/s12931-024-02843-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2024] [Accepted: 05/08/2024] [Indexed: 06/22/2024] Open
Abstract
OBJECTIVES To assess the effectiveness of HRCT-based radiomics in predicting rapidly progressive interstitial lung disease (RP-ILD) and mortality in anti-MDA5 positive dermatomyositis-related interstitial lung disease (anti-MDA5 + DM-ILD). METHODS From August 2014 to March 2022, 160 patients from Institution 1 were retrospectively and consecutively enrolled and were randomly divided into the training dataset (n = 119) and internal validation dataset (n = 41), while 29 patients from Institution 2 were retrospectively and consecutively enrolled as external validation dataset. We generated four Risk-scores based on radiomics features extracted from four areas of HRCT. A nomogram was established by integrating the selected clinico-radiologic variables and the Risk-score of the most discriminative radiomics model. The RP-ILD prediction performance of the models was evaluated by using the area under the receiver operating characteristic curves, calibration curves, and decision curves. Survival analysis was conducted with Kaplan-Meier curves, Mantel-Haenszel test, and Cox regression. RESULTS Over a median follow-up time of 31.6 months (interquartile range: 12.9-49.1 months), 24 patients lost to follow-up and 46 patients lost their lives (27.9%, 46/165). The Risk-score based on bilateral lungs performed best, attaining AUCs of 0.869 and 0.905 in the internal and external validation datasets. The nomogram outperformed clinico-radiologic model and Risk-score with AUCs of 0.882 and 0.916 in the internal and external validation datasets. Patients were classified into low- and high-risk groups with 50:50 based on nomogram. High-risk group patients demonstrated a significantly higher risk of mortality than low-risk group patients in institution 1 (HR = 4.117) and institution 2 cohorts (HR = 7.515). CONCLUSION For anti-MDA5 + DM-ILD, the nomogram, mainly based on radiomics, can predict RP-ILD and is an independent predictor of mortality.
Collapse
Affiliation(s)
- Wenzhang He
- Department of Radiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610000, China
- Department of Radiology, Chongqing General Hospital, Chongqing University, Chongqing, China
| | - Beibei Cui
- Department of Rheumatology and Immunology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, Sichuan, 610000, China
| | - Zhigang Chu
- Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - Xiaoyi Chen
- Department of Radiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610000, China
| | - Jing Liu
- Department of Radiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610000, China
| | - Xueting Pang
- Department of Radiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610000, China
| | - Xuan Huang
- Biomedical Big Data Center, West China School of Medicine, West China Hospital, Sichuan University, Chengdu, China
| | - Hongkun Yin
- Institute of Advanced Research, Infervision Medical Technology, Beijing, China
| | - Hui Lin
- Department of Rheumatology and Immunology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, Sichuan, 610000, China.
| | - Liqing Peng
- Department of Radiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610000, China.
| |
Collapse
|
2
|
Lemaire R, Raboutet C, Leleu T, Jaudet C, Dessoude L, Missohou F, Poirier Y, Deslandes PY, Lechervy A, Lacroix J, Moummad I, Bardet S, Thariat J, Stefan D, Corroyer-Dulmont A. Artificial intelligence solution to accelerate the acquisition of MRI images: Impact on the therapeutic care in oncology in radiology and radiotherapy departments. Cancer Radiother 2024; 28:251-257. [PMID: 38866650 DOI: 10.1016/j.canrad.2023.11.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Accepted: 11/28/2023] [Indexed: 06/14/2024]
Abstract
PURPOSE MRI is essential in the management of brain tumours. However, long waiting times reduce patient accessibility. Reducing acquisition time could improve access but at the cost of spatial resolution and diagnostic quality. A commercially available artificial intelligence (AI) solution, SubtleMR™, can increase the resolution of acquired images. The objective of this prospective study was to evaluate the impact of this algorithm that halves the acquisition time on the detectability of brain lesions in radiology and radiotherapy. MATERIAL AND METHODS The T1/T2 MRI of 33 patients with brain metastases or meningiomas were analysed. Images acquired quickly have a matrix divided by two which halves the acquisition time. The visual quality and lesion detectability of the AI images were evaluated by radiologists and radiation oncologist as well as pixel intensity and lesions size. RESULTS The subjective quality of the image is lower for the AI images compared to the reference images. However, the analysis of lesion detectability shows a specificity of 1 and a sensitivity of 0.92 and 0.77 for radiology and radiotherapy respectively. Undetected lesions on the IA image are lesions with a diameter less than 4mm and statistically low average gadolinium-enhancement contrast. CONCLUSION It is possible to reduce MRI acquisition times by half using the commercial algorithm to restore the characteristics of the image and obtain good specificity and sensitivity for lesions with a diameter greater than 4mm.
Collapse
Affiliation(s)
- R Lemaire
- Medical Physics Department, centre François-Baclesse, 14000 Caen, France
| | - C Raboutet
- Radiology Department, centre François-Baclesse, 14000 Caen, France
| | - T Leleu
- Radiotherapy Department, centre François-Baclesse, 14000 Caen, France
| | - C Jaudet
- Medical Physics Department, centre François-Baclesse, 14000 Caen, France
| | - L Dessoude
- Radiotherapy Department, centre François-Baclesse, 14000 Caen, France
| | - F Missohou
- Radiotherapy Department, centre François-Baclesse, 14000 Caen, France
| | - Y Poirier
- Radiology Department, centre François-Baclesse, 14000 Caen, France
| | - P-Y Deslandes
- Informatics Department, centre François-Baclesse, 14000 Caen, France
| | - A Lechervy
- UMR Greyc, Normandie Université, UniCaen, EnsiCaen, CNRS, 14000 Caen, France
| | - J Lacroix
- Radiology Department, centre François-Baclesse, 14000 Caen, France
| | - I Moummad
- Medical Physics Department, centre François-Baclesse, 14000 Caen, France; IMT Atlantique, Lab-Sticc, UMR CNRS 6285, 29238 Brest, France
| | - S Bardet
- Nuclear Medicine Department, centre François-Baclesse, 14000 Caen, France
| | - J Thariat
- Radiotherapy Department, centre François-Baclesse, 14000 Caen, France
| | - D Stefan
- Radiotherapy Department, centre François-Baclesse, 14000 Caen, France
| | - A Corroyer-Dulmont
- Medical Physics Department, centre François-Baclesse, 14000 Caen, France; Université de Caen Normandie, CNRS, Normandie Université, ISTCT UMR6030, GIP Cyceron, 14000 Caen, France.
| |
Collapse
|
3
|
Tran AT, Zeevi T, Haider SP, Abou Karam G, Berson ER, Tharmaseelan H, Qureshi AI, Sanelli PC, Werring DJ, Malhotra A, Petersen NH, de Havenon A, Falcone GJ, Sheth KN, Payabvash S. Uncertainty-aware deep-learning model for prediction of supratentorial hematoma expansion from admission non-contrast head computed tomography scan. NPJ Digit Med 2024; 7:26. [PMID: 38321131 PMCID: PMC10847454 DOI: 10.1038/s41746-024-01007-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Accepted: 01/10/2024] [Indexed: 02/08/2024] Open
Abstract
Hematoma expansion (HE) is a modifiable risk factor and a potential treatment target in patients with intracerebral hemorrhage (ICH). We aimed to train and validate deep-learning models for high-confidence prediction of supratentorial ICH expansion, based on admission non-contrast head Computed Tomography (CT). Applying Monte Carlo dropout and entropy of deep-learning model predictions, we estimated the model uncertainty and identified patients at high risk of HE with high confidence. Using the receiver operating characteristics area under the curve (AUC), we compared the deep-learning model prediction performance with multivariable models based on visual markers of HE determined by expert reviewers. We randomly split a multicentric dataset of patients (4-to-1) into training/cross-validation (n = 634) versus test (n = 159) cohorts. We trained and tested separate models for prediction of ≥6 mL and ≥3 mL ICH expansion. The deep-learning models achieved an AUC = 0.81 for high-confidence prediction of HE≥6 mL and AUC = 0.80 for prediction of HE≥3 mL, which were higher than visual maker models AUC = 0.69 for HE≥6 mL (p = 0.036) and AUC = 0.68 for HE≥3 mL (p = 0.043). Our results show that fully automated deep-learning models can identify patients at risk of supratentorial ICH expansion based on admission non-contrast head CT, with high confidence, and more accurately than benchmark visual markers.
Collapse
Grants
- K23 NS110980 NINDS NIH HHS
- U24 NS107136 NINDS NIH HHS
- UL1 TR001863 NCATS NIH HHS
- K76 AG059992 NIA NIH HHS
- P30 AG021342 NIA NIH HHS
- R03 NS112859 NINDS NIH HHS
- U24 NS107215 NINDS NIH HHS
- U01 NS106513 NINDS NIH HHS
- 2020097 Doris Duke Charitable Foundation
- K23 NS118056 NINDS NIH HHS
- R01 NR018335 NINR NIH HHS
- Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.)
- Doris Duke Charitable Foundation (DDCF)
- Doris Duke Charitable Foundation (2020097), American Society of Neuroradiology, and National Institutes of Health (K23NS118056).
- National Institutes of Health (K76AG059992, R03NS112859, and P30AG021342), the American Heart Association (18IDDG34280056), the Yale Pepper Scholar Award, and the Neurocritical Care Society Research Fellowship
- National Institutes of Health (U24NS107136, U24NS107215, R01NR018335, and U01NS106513) and the American Heart Association (18TPA34170180 and 17CSA33550004) and a Hyperfine Research Inc research grant.
Collapse
Affiliation(s)
- Anh T Tran
- Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
| | - Tal Zeevi
- Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
| | - Stefan P Haider
- Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
- Department of Otorhinolaryngology, University Hospital of Ludwig Maximilians Universität München, Munich, Germany
| | - Gaby Abou Karam
- Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
| | - Elisa R Berson
- Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
| | - Hishan Tharmaseelan
- Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
| | - Adnan I Qureshi
- Stroke Institute and Department of Neurology, University of Missouri, Columbia, MO, USA
| | - Pina C Sanelli
- Department of Radiology, Northwell Health, Manhasset, NY, USA
| | - David J Werring
- Stroke Research Centre, University College London, Queen Square Institute of Neurology, London, UK
| | - Ajay Malhotra
- Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
| | - Nils H Petersen
- Department of Neurology, Yale School of Medicine, New Haven, CT, USA
| | - Adam de Havenon
- Department of Neurology, Yale School of Medicine, New Haven, CT, USA
| | - Guido J Falcone
- Department of Neurology, Yale School of Medicine, New Haven, CT, USA
| | - Kevin N Sheth
- Department of Neurology, Yale School of Medicine, New Haven, CT, USA.
| | - Seyedmehdi Payabvash
- Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
| |
Collapse
|
4
|
Patwari M, Gutjahr R, Marcus R, Thali Y, Calvarons AF, Raupach R, Maier A. Reducing the risk of hallucinations with interpretable deep learning models for low-dose CT denoising: comparative performance analysis. Phys Med Biol 2023; 68:19LT01. [PMID: 37733068 DOI: 10.1088/1361-6560/acfc11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Accepted: 09/21/2023] [Indexed: 09/22/2023]
Abstract
Objective.Reducing CT radiation dose is an often proposed measure to enhance patient safety, which, however results in increased image noise, translating into degradation of clinical image quality. Several deep learning methods have been proposed for low-dose CT (LDCT) denoising. The high risks posed by possible hallucinations in clinical images necessitate methods which aid the interpretation of deep learning networks. In this study, we aim to use qualitative reader studies and quantitative radiomics studies to assess the perceived quality, signal preservation and statistical feature preservation of LDCT volumes denoised by deep learning. We aim to compare interpretable deep learning methods with classical deep neural networks in clinical denoising performance.Approach.We conducted an image quality analysis study to assess the image quality of the denoised volumes based on four criteria to assess the perceived image quality. We subsequently conduct a lesion detection/segmentation study to assess the impact of denoising on signal detectability. Finally, a radiomic analysis study was performed to observe the quantitative and statistical similarity of the denoised images to standard dose CT (SDCT) images.Main results.The use of specific deep learning based algorithms generate denoised volumes which are qualitatively inferior to SDCT volumes(p< 0.05). Contrary to previous literature, denoising the volumes did not reduce the accuracy of the segmentation (p> 0.05). The denoised volumes, in most cases, generated radiomics features which were statistically similar to those generated from SDCT volumes (p> 0.05).Significance.Our results show that the denoised volumes have a lower perceived quality than SDCT volumes. Noise and denoising do not significantly affect detectability of the abdominal lesions. Denoised volumes also contain statistically identical features to SDCT volumes.
Collapse
Affiliation(s)
- Mayank Patwari
- Pattern Recognition Lab, Friedrich-Alexander Universität Erlangen-Nürnberg, D-91058 Erlangen, Germany
- CT Concepts, Siemens Healthineers AG, D-91301 Forchheim, Germany
| | - Ralf Gutjahr
- CT Concepts, Siemens Healthineers AG, D-91301 Forchheim, Germany
| | - Roy Marcus
- Balgrist University Hospital Zurich, 8008 Zurich, Switzerland
- Faculty of Medicine, University of Zurich, 8032 Zurich, Switzerland
- Cantonal Hospital of Lucerne, 6016 Lucerne, Switzerland
| | - Yannick Thali
- Spital Zofingen AG, 4800 Zofingen, Switzerland
- Cantonal Hospital of Lucerne, 6016 Lucerne, Switzerland
| | | | - Rainer Raupach
- CT Concepts, Siemens Healthineers AG, D-91301 Forchheim, Germany
| | - Andreas Maier
- Pattern Recognition Lab, Friedrich-Alexander Universität Erlangen-Nürnberg, D-91058 Erlangen, Germany
| |
Collapse
|
5
|
Palani D, Ganesh KM, Karunagaran L, Govindaraj K, Shanmugam S. Statistical Analysis on Impact of Image Preprocessing of CT Texture Patterns and Its CT Radiomic Feature Stability: A Phantom Study. Asian Pac J Cancer Prev 2023; 24:2061-2072. [PMID: 37378937 PMCID: PMC10505874 DOI: 10.31557/apjcp.2023.24.6.2061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Accepted: 06/23/2023] [Indexed: 06/29/2023] Open
Abstract
AIM To examine computed tomography (CT) radiomic feature stability on various texture patterns during pre-processing utilizing the Credence Cartridge Radiomics (CCR) phantom textures. MATERIALS AND METHODS Imaging Biomarker Explorer (IBEX) expansion for the abbreviation IBEX extracted 51 radiomic features of 4 categories from 11 textures image regions of interest (ROI) of the phantom. 19 software pre-processing algorithms processed each CCR phantom ROI. All ROI texture processed image features were retrieved. Pre-processed CT image radiomic features were compared to non-processed features to measure its textural influence. Wilcoxon T-tests measured the pre-processing relevance of CT radiomic features on various textures. Hierarchical cluster analysis (HCA) was performed to cluster processer potency and texture impression likeness. RESULTS The pre-processing filter, CT texture Cartridge, and feature category affect the CCR phantom CT image's radiomic properties. Pre-processing is statistically unaltered by Gray Level Run Length Matrix (GLRLM ) expansion for the abbreviation GLRLM and Neighborhood Intensity Difference matrix (NID) expansion for the abbreviation NID feature categories. The 30%, 40%, and 50% honeycomb are regular directional textures and smooth 3D-printed plaster resin, most of the image pre-processing feature alterations exhibited significant p-values in the histogram feature category. The Laplacian Filter, Log Filter, Resample, and Bit Depth Rescale Range pre-processing algorithms hugely influenced histogram and Gray Level Co-occurrence Matrix (GLCM) image features. CONCLUSION We found that homogenous intensity phantom inserts, CT radiomic feature, are less sensitive to feature swaps during pre-processing than normal directed honeycomb and regular projected smooth 3D-printed plaster resin CT image textures. Because they lose fewer information during image enhancement, This feature concentration empowerment of the images also enhances texture pattern recognition.
Collapse
Affiliation(s)
- Dharmendran Palani
- Research and Development Centre, Bharathiar University, Coimbatore, India.
| | - Kadirampatti M. Ganesh
- Department of Radiation Physics, Kidwai Memorial Institute of Oncology, Bengaluru, India.
| | - Lavanya Karunagaran
- Department of Oral and Maxillofacial Pathology, Asan Memorial Dental College and Hospital, Chennai, India.
| | - Kesavan Govindaraj
- Department of Radiotherapy, Vadamalayan Hospitals Integrated Cancer Centre, Madurai, India.
| | - Senthilkumar Shanmugam
- Department of Radiotherapy Government Rajaji Hospital & Madurai Medical College, Madurai, India.
| |
Collapse
|
7
|
Lyu Q, Namjoshi SV, McTyre E, Topaloglu U, Barcus R, Chan MD, Cramer CK, Debinski W, Gurcan MN, Lesser GJ, Lin HK, Munden RF, Pasche BC, Sai KK, Strowd RE, Tatter SB, Watabe K, Zhang W, Wang G, Whitlow CT. A transformer-based deep-learning approach for classifying brain metastases into primary organ sites using clinical whole-brain MRI images. PATTERNS 2022; 3:100613. [PMID: 36419451 PMCID: PMC9676537 DOI: 10.1016/j.patter.2022.100613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/30/2022] [Revised: 07/08/2022] [Accepted: 09/28/2022] [Indexed: 11/05/2022]
Abstract
Treatment decisions for brain metastatic disease rely on knowledge of the primary organ site and are currently made with biopsy and histology. Here, we develop a deep-learning approach for accurate non-invasive digital histology with whole-brain magnetic resonance imaging (MRI) data. Contrast-enhanced T1-weighted and fast spoiled gradient echo brain MRI exams (n = 1,582) were preprocessed and input to the proposed deep-learning workflow for tumor segmentation, modality transfer, and primary site classification into one of five classes. Tenfold cross-validation generated an overall area under the receiver operating characteristic curve (AUC) of 0.878 (95% confidence interval [CI]: 0.873,0.883). These data establish that whole-brain imaging features are discriminative enough to allow accurate diagnosis of the primary organ site of malignancy. Our end-to-end deep radiomic approach has great potential for classifying metastatic tumor types from whole-brain MRI images. Further refinement may offer an invaluable clinical tool to expedite primary cancer site identification for precision treatment and improved outcomes.
Collapse
Affiliation(s)
- Qing Lyu
- Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA
| | - Sanjeev V. Namjoshi
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Emory McTyre
- Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Radiology Informatics & Image Processing Laboratory, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Umit Topaloglu
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Richard Barcus
- Radiology Informatics & Image Processing Laboratory, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Radiology, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Michael D. Chan
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Christina K. Cramer
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Waldemar Debinski
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Metin N. Gurcan
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Glenn J. Lesser
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Hui-Kuan Lin
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Reginald F. Munden
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Radiology, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Boris C. Pasche
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Kiran K.S. Sai
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Radiology Informatics & Image Processing Laboratory, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Radiology, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Roy E. Strowd
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Stephen B. Tatter
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Kounosuke Watabe
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Wei Zhang
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Ge Wang
- Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA
- Corresponding author
| | - Christopher T. Whitlow
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Brain Tumor Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Radiology Informatics & Image Processing Laboratory, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Radiology, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Biomedical Engineering, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Corresponding author
| |
Collapse
|